News Alerts

20 Apr 2018 | 03:38 AM UTC

Niger: Nationwide meningitis outbreak kills 24 as of April 19

Niger News Alert

Nationwide meningitis outbreak; 306 cases and 24 deaths reported in 2018 as of April 19

TIMEFRAME expected from 4/19/2018, 12:00 AM until 4/26/2018, 11:59 PM (Africa/Niamey). COUNTRY/REGION Niger


According to health officials, at least 306 cases of meningitis, including 24 fatal cases, have been reported nationwide since January 1 amid an ongoing meningitis outbreak as of April 19. The capital city of Niamey is among the most affected areas. Health officials and NGOs in the area have reportedly implemented public health measures, including vaccination campaigns, to contain the spread of the disease.


Meningitis is hyperendemic to the "meningitis belt" of Africa's Sahel region, which stretches from Senegal to Ethiopia, and is an annual concern in the region as periodic outbreaks occur during the dry season between October and April.

Symptoms of meningitis, a contagious bacterial disease that can cause infections in the lining of the brain and/or in the blood, include fever, headache, a stiff neck, nausea, vomiting, increased sensitivity to light, joint and muscle pains, and a rash. Without appropriate medical treatment, the disease is fatal in approximately 50 percent of cases. A vaccine is available.


Individuals present in Niger are advised to take the necessary measures to protect themselves from the disease (wash hands and disinfect all surfaces frequently), avoid all contact with infected individuals, and make sure appropriate immunizations are up to date before traveling to the country. Individuals developing symptoms of the disease should seek immediate medical attention.


Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news